Documents to download

Medical tourism refers to when people seek medical treatment in a different country than the one they reside. In the context of this brief it refers to UK residents seeking elective, non-emergency medical treatment abroad.

Some writers have objected to the use of the term medical tourism because they consider it has connotations of leisure, frivolity and pleasure that may be inappropriate when applied to those seeking medical treatments such as dental care, fertility treatments, or bariatric or cosmetic surgery. However, the term has become widely used to describe such behaviour.

While there is a range of estimates of medical tourists, the consultancy Deloitte estimated that 750,000 US citizens sought medical treatments abroad in 2007, and projected that this figure would rise to 3–5 million by 2010. Deloitte suggested that American citizens represent around 10% of the global medical tourism market, although it is unclear what this assumption is based on. This would put the size of the global market as somewhere between 0.5 million and 50 million people a year,

There is a lack of reliable sources of medical tourism data. But the International Passenger Survey (IPS) conducted each year by the Office for National Statistics (ONS) found that in 2016 nearly 144,000 UK citizens travelled abroad for medical treatment. The survey suggests a steady increase since 2000, even though the 2016 sample of 250,000 travellers represent 0.23% of the total number of travellers entering or leaving the UK.

In 2016 UK citizens travelled to 31 different countries for medical treatment. Eight countries accounted for 72% of all such visits, including Poland, Hungary, Romania, Turkey, Spain, France, Latvia and Lithuania. Of the remaining 28% of visits, the three most frequently visited destinations in 2016 were Switzerland, Greece and India.

A 2014 review of the medical tourism literature identified four main types of treatment commonly sought by UK citizens abroad. These include fertility treatments, cosmetic surgery, bariatric surgery  and dental surgery.

European data suggest that around 24–30,000 cycles of cross-border fertility treatment involving 11–14,000 patients are performed in Europe each year. Seeking fertility treatments abroad allows medical tourists to circumvent restrictions and access the donated sperm and eggs they want. This can be coupled with a perception of higher success rates in the destination country.

Some evidence from the British Association of Plastic Reconstructive and Aesthetic Surgeons suggests that a non-negligible number of medical tourists who undergo cosmetic surgery return to the UK in need of further treatment.

Limited qualitative data on bariatric surgery patients (patients who have undergone gastric bypass or gastric banding, sheds light on their motivations for medical tourism. These include travelling to receive higher grade medical care, travelling for operations perceived us inaccessible to them in the UK and travelling to reduce the cost of the procedure.

Dentistry is also popular among medical tourists, with some patients citing reasons such as lack of availability of dental services on the NHS, distrust of NHS dentistry, dissatisfaction with previous NHS dental treatment and cost.

Literature reviews and surveys have identified a number of issues that may be faced by people seeking treatment abroad. These include additional risks associated with treatments abroad, professional advice available to patients, quality assessment and accreditation, regulation of advertising of medical treatments and follow-up care.


Documents to download

Related posts

  • Some occupational groups have experienced higher rates of both COVID-19 infections and related deaths. Many people who work within these groups are involved in caring for people or patients that are more likely to be infected, or have otherwise been unable to work from home during the peaks of transmission. Which occupations have been most affected, what factors are contributing to this risk and are some sectors of the population being impacted more than others?

  • During the first 6 months of the pandemic, people from ethnic minority groups were more likely to have COVID-19 disease and also more likely to experience severe outcomes from infection, including death. Lockdown measures have also disproportionately affected some communities more than others. What is driving this increased prevalence and death rates in ethnic minority groups? To what extent is it due to biology or pre-existing health? Or does it represent a continuation and exacerbation of social inequalities?

  • On 9 September, the Prime Minister announced a moonshot plan for mass COVID-19 testing. Recently there have been capacity issues in the NHS Test and Trace programme and current technologies cannot be scaled easily to millions of tests per day. So, how is COVID-19 testing undertaken, how reliable are current tests, and what technologies or strategies are emerging that would make this moonshot feasible?